Sustained improvement in cardiac function with single dose cimaglermin alfa (GGF 2) in human left ventricular systolic dysfunction

Authors
Category Primary study
JournalJournal of the American College of Cardiology
Year 2015
This article has no abstract
Epistemonikos ID: 95a3b6c571d83c1557cdbcaf0525b88c0e25212f
First added on: Feb 07, 2025